Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Biologics
Chicago, Illinois, United States
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
Cell Biologics primarily supplies primary cell products (including human and animal cells like endothelial, epithelial, bone marrow, liver, tumor, and stem cells) for research. They are also developing early-stage therapeutic platforms, mainly for inflammatory diseases and biologics delivery, but are not a clinical-stage company and do not have marketed therapeutics.
- Therapeutic areas
- CardiovascularOncologyImmunology
- Modalities
- BiologicCell therapyRecombinant protein
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Cell Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell Biologics.